LabGenomics
Clinical diagnostics company that develops and manufactures molecular and immunodiagnostic kits and provides laboratory testing services. Documented capabilities include next-generation sequencing (NGS) assays (oncology, prenatal, newborn screening), PCR-based and antigen immunoassays, microbiome profiling, direct-to-consumer genetic tests, laboratory-developed tests (LDTs), and CLIA-based US laboratory operations. The company reports regulatory and quality certifications (ISO 13485, GMP recognition, CAP participation, ISO 27001/27701), international laboratory partnerships, and recent product launches and service contracts expanding oncology NGS and liquid biopsy offerings.
Industries
Nr. of Employees
small (1-50)
LabGenomics
Bundangdong, Kyonggi-do, South Korea, Asia
Products
PCR-based diagnostic kits
Real-time PCR and RT-PCR kits for infectious disease detection and molecular genotyping, including targeted detection assays such as HLA typing.
Antigen rapid diagnostic tests
Immunodiagnostic rapid antigen tests intended for point-of-care or screening use.
Genotyping and HLA detection kits
Kits for targeted genotyping and HLA allele detection used in clinical diagnostics and research.
Comprehensive oncology NGS panel (pan-cancer)
Pan-cancer NGS panel intended for broad oncology testing across tumor types and clinical indications.
PCR-based diagnostic kits
Real-time PCR and RT-PCR kits for infectious disease detection and molecular genotyping, including targeted detection assays such as HLA typing.
Antigen rapid diagnostic tests
Immunodiagnostic rapid antigen tests intended for point-of-care or screening use.
Genotyping and HLA detection kits
Kits for targeted genotyping and HLA allele detection used in clinical diagnostics and research.
Comprehensive oncology NGS panel (pan-cancer)
Pan-cancer NGS panel intended for broad oncology testing across tumor types and clinical indications.
Services
Molecular diagnostic testing services
Clinical molecular testing services including NGS-based oncology tests, non-invasive prenatal testing (NIPT), newborn metabolic and hearing screening, and developmental disorder panels.
Direct-to-consumer genetic testing
Consumer genetic tests for trait and disease predisposition reporting via order and mail-in sample processes.
Microbiome testing services
Microbial community profiling from oral and vaginal samples with reporting for clinical or consumer use.
Liquid biopsy testing service
Clinical testing service based on circulating tumor DNA sequencing for oncology applications (liquid biopsy).
Reference laboratory services (US)
Clinical testing services delivered through CLIA-certified reference laboratory partnerships and acquisitions in the United States.
Molecular diagnostic testing services
Clinical molecular testing services including NGS-based oncology tests, non-invasive prenatal testing (NIPT), newborn metabolic and hearing screening, and developmental disorder panels.
Direct-to-consumer genetic testing
Consumer genetic tests for trait and disease predisposition reporting via order and mail-in sample processes.
Microbiome testing services
Microbial community profiling from oral and vaginal samples with reporting for clinical or consumer use.
Liquid biopsy testing service
Clinical testing service based on circulating tumor DNA sequencing for oncology applications (liquid biopsy).
Reference laboratory services (US)
Clinical testing services delivered through CLIA-certified reference laboratory partnerships and acquisitions in the United States.
Expertise Areas
- Molecular diagnostics
- Oncology NGS panels and liquid biopsy
- PCR-based assay design and kit manufacturing
- Prenatal and newborn genetic screening
Key Technologies
- Next-generation sequencing (NGS)
- Liquid biopsy / circulating tumor DNA (ctDNA) sequencing
- Real-time PCR and RT-PCR
- Antigen immunoassays